Literature DB >> 11983227

The establishment of a combined serum-free and serum-supplemented culture method of obtaining functional cord blood-derived human mast cells.

Christine Dahl1, Hirohisa Saito, Henrik Vendelbo Nielsen, Peter Oluf Schiøtz.   

Abstract

BACKGROUND: Serum-free cultures supplemented with stem cell factor (SCF) and IL-6 is reported to support the extensive growth of less functional human cord blood-derived mast cells.
OBJECTIVE: To obtain more functional mast cells from cord blood, we developed a culture system combining a serum-free condition for 0-8 weeks of culture, and followed by a serum-supplemented culture condition and examined the function of the cells compared to the cells cultured continuously in serum-free condition.
METHODS: Human cord blood progenitors were purified with anti-CD133 antibody. They were cultured in a serum-free medium StemSpan supplemented with SCF at 100 ng/ml and IL-6 at 50 ng/ml for 8 weeks. Then, an aliquot of the cultured cells were cultured in the above condition but further supplemented with 10% fetal calf serum (FCS).
RESULTS: The addition of FCS after 8 weeks of culture significantly increased the amount of histamine per mast cell (3.8 pg/cell) when compared to the serum-free condition (0.7 pg/cell). The cells cultured with FCS after 8 weeks expressed more FcvarepsilonRI alpha and released >30% of the histamine content upon anti-IgE stimulation than those cultured without serum.
CONCLUSION: It is uncertain why FCS enhanced the functional maturation of mast cells when added after week 8 of culture but suppressed mast cell development when added at day 0 of culture. Yet, the present method combining a serum-free culture system with a serum-supplemented culture system seems to be beneficial for most of the laboratories to obtain functional human mast cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983227     DOI: 10.1016/s0022-1759(02)00011-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

Review 1.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

2.  Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis.

Authors:  Rajia Bahri; Orsolya Kiss; Ian Prise; Karen M Garcia-Rodriguez; Haris Atmoko; Julia M Martínez-Gómez; Mitchell P Levesque; Reinhard Dummer; Michael P Smith; Claudia Wellbrock; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

3.  Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors.

Authors:  Megan M Price; Dmitri Kapitonov; Jeremy Allegood; Sheldon Milstien; Carole A Oskeritzian; Sarah Spiegel
Journal:  FASEB J       Date:  2009-06-17       Impact factor: 5.191

4.  Periodic acid‑Schiff staining method for function detection of liver cells is affected by 2% horse serum in induction medium.

Authors:  Hui Hui; Wenjun Ma; Jiejie Cui; Mengjia Gong; Yi Wang; Yuanyuan Zhang; Tongchuan He; Yang Bi; Yun He
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

5.  A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions.

Authors:  Andrea Mencarelli; Merry Gunawan; Kylie Su Mei Yong; Pradeep Bist; Wilson Wei Sheng Tan; Sue Yee Tan; Min Liu; Edwin Kunxiang Huang; Yong Fan; Jerry Kok Yen Chan; Hae Woong Choi; Soman N Abraham; Qingfeng Chen
Journal:  J Leukoc Biol       Date:  2020-01-10       Impact factor: 6.011

6.  Development of Human Mast Cells from Hematopoietic Stem Cells within a 3D Collagen Matrix: Effect of Stem Cell Media on Mast Cell Generation.

Authors:  Tahereh Derakhshan; Rudra Bhowmick; Jerry W Ritchey; Heather Gappa-Fahlenkamp
Journal:  Stem Cells Int       Date:  2018-07-11       Impact factor: 5.443

7.  Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1.

Authors:  Samia Yazid; Ajantha Sinniah; Egle Solito; Virginia Calder; Rod J Flower
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

8.  Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.

Authors:  Yingxin Yu; Bart R J Blokhuis; Mara A P Diks; Ali Keshavarzian; Johan Garssen; Frank A Redegeld
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.